-
SRPT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Sarepta Therapeutics (SRPT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 213.43 mm | 213.43 mm | 213.43 mm | 213.43 mm | 213.43 mm | 213.43 mm |
Cash burn (monthly) | 61.92 mm | 28.97 mm | (no burn) | (no burn) | 23.57 mm | 29.37 mm |
Cash used (since last report) | 263.69 mm | 123.37 mm | n/a | n/a | 100.36 mm | 125.09 mm |
Cash remaining | -50.26 mm | 90.06 mm | n/a | n/a | 113.08 mm | 88.35 mm |
Runway (months of cash) | -0.8 | 3.1 | n/a | n/a | 4.8 | 3.0 |
13F holders | Current |
---|---|
Total holders | 459 |
Opened positions | 60 |
Closed positions | 86 |
Increased positions | 168 |
Reduced positions | 154 |
13F shares | Current |
---|---|
Total value | 10.08 tn |
Total shares | 85.91 mm |
Total puts | 1.40 mm |
Total calls | 1.97 mm |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 11.02 mm | $1.38 tn |
Vanguard | 8.97 mm | $1.12 tn |
Capital International Investors | 6.26 mm | $781.72 bn |
JHG Janus Henderson | 4.36 mm | $544.41 bn |
STT State Street | 4.27 mm | $533.38 bn |
Wellington Management | 2.73 mm | $340.53 bn |
Farallon Capital Management | 2.58 mm | $322.22 bn |
Avoro Capital Advisors | 2.56 mm | $319.16 bn |
JPM JPMorgan Chase & Co. | 2.20 mm | $274.62 bn |
BK The Bank of New York Mellon Corporation | 2.12 mm | $264.63 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 25 | Ian Michael Estepan | Common Stock | Payment of exercise | Dispose F | No | No | 117.51 | 2,613 | 307.05 k | 46,883 |
29 Jan 25 | Ian Michael Estepan | Common Stock | Option exercise | Acquire M | No | No | 12 | 1,533 | 18.40 k | 49,496 |
29 Jan 25 | Ian Michael Estepan | Common Stock | Option exercise | Acquire M | No | No | 12 | 14,267 | 171.20 k | 47,963 |
29 Jan 25 | Ian Michael Estepan | Stock Option Common Stock | Option exercise | Dispose M | No | No | 12 | 1,533 | 18.40 k | 0 |
29 Jan 25 | Ian Michael Estepan | Stock Option Common Stock | Option exercise | Dispose M | No | No | 12 | 14,267 | 171.20 k | 0 |
27 Dec 24 | Ian Michael Estepan | Common Stock | Gift | Dispose G | No | No | 0 | 250 | 0.00 | 33,696 |
12 Dec 24 | Hans Lennart Rudolf Wigzell | Common Stock | Sell | Dispose S | No | No | 124.84 | 10,500 | 1.31 mm | 22,840 |
12 Dec 24 | Hans Lennart Rudolf Wigzell | Common Stock | Option exercise | Acquire M | No | No | 13.71 | 10,500 | 143.96 k | 33,340 |
12 Dec 24 | Hans Lennart Rudolf Wigzell | Stock Options Common Stock | Option exercise | Dispose M | No | No | 13.71 | 10,500 | 143.96 k | 0 |
5 Dec 24 | Kathryn Jean Boor | Common Stock | Sell | Dispose S | No | No | 125.55 | 1,636 | 205.40 k | 5,880 |